CHORD ENERGY CORP
CHRDNASDAQ🏆 #931 by market capEarnings Nov 4 · PostUS Equity
$154.06▲ $0.75 (+0.49%)
🌅 Pre-market$155.50▲ 0.93%Regular close · extended-hours price shownTrack CHRD
Get earnings, price moves & breaking news on Telegram
24h▲ 0.5%
7d▲ 2.3%
14d▲ 3.9%
30d▲ 14.7%
ytd▲ 66.2%
1y▲ 69.3%
🏦Market Cap
$8.43B
Small Cap
📈Revenue Growth (YoY)
19.2%
Healthy
📊Gross Margin
49.7%
Healthy
💵FCF Margin
17.0%
Healthy
⚖️P/S Ratio
1.3x
Cheap
Otter Score
88
Excellent
CHORD ENERGY CORP
CHRDAnalyst Ratings
Price
$154.06
Total
20
Raised
1
Lowered
2
Avg PT
$178.75
H / L
$197 / $150
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Buy | 2026-10-20 | $197.00 | +27.90% |
Morgan Stanley | Reiterated | Overweight | 2026-10-15 | $178.00 | +15.50% |
Wells Fargo | Reiterated | Overweight | 2026-10-14 | $174.00 | +12.90% |
Truist Securities | Reiterated | Buy | 2026-10-12 | — | — |
Mizuho | Reiterated | Outperform | 2026-10-05 | — | — |
Jefferies | Reiterated | Hold | 2026-09-18 | $150.00 | −2.60% |
Citigroup | Reiterated | Neutral | 2026-09-17 | — | — |
Scotiabank | Reiterated | Sector Perform | 2026-04-22 | $192.00 | +24.60% |
Roth Capital | Reiterated | Buy | 2026-04-17 | $165.00 | +7.10% |
Piper Sandler | Reiterated | Overweight | 2026-03-12 | $151.00 | −2.00% |
RBC Capital | Reiterated | Outperform | 2026-01-13 | $128.00 | −16.90% |
B of A Securities | Reiterated | Buy | 2025-09-17 | — | — |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2025-01-03 | $155.00 | +0.60% |
BMO Capital | Reiterated | Outperform | 2024-10-04 | $230.00 | +49.30% |
Stifel | Reiterated | Buy | 2024-02-27 | — | — |
TD Cowen | Downgraded | Outperform → Market Perform | 2023-07-19 | — | — |
MKM Partners | Reiterated | Buy | 2022-03-07 | — | — |
Raymond James | Reiterated | Outperform | 2020-02-26 | — | — |
SunTrust Robinson Humphrey | Reiterated | Sell | 2020-02-26 | — | — |
Susquehanna | Downgraded | Positive → Negative | 2020-01-12 | — | — |
Institution
UBS
Reiterated · Buy · 2026-10-20
$197.00
+27.90%
Morgan Stanley
Reiterated · Overweight · 2026-10-15
$178.00
+15.50%
Wells Fargo
Reiterated · Overweight · 2026-10-14
$174.00
+12.90%
Truist Securities
Reiterated · Buy · 2026-10-12
—
—
Mizuho
Reiterated · Outperform · 2026-10-05
—
—
Jefferies
Reiterated · Hold · 2026-09-18
$150.00
−2.60%
Citigroup
Reiterated · Neutral · 2026-09-17
—
—
Scotiabank
Reiterated · Sector Perform · 2026-04-22
$192.00
+24.60%
Roth Capital
Reiterated · Buy · 2026-04-17
$165.00
+7.10%
Piper Sandler
Reiterated · Overweight · 2026-03-12
$151.00
−2.00%
RBC Capital
Reiterated · Outperform · 2026-01-13
$128.00
−16.90%
B of A Securities
Reiterated · Buy · 2025-09-17
—
—
Wolfe Research
Upgraded · Peer Perform → Outperform · 2025-01-03
$155.00
+0.60%
BMO Capital
Reiterated · Outperform · 2024-10-04
$230.00
+49.30%
Stifel
Reiterated · Buy · 2024-02-27
—
—
TD Cowen
Downgraded · Outperform → Market Perform · 2023-07-19
—
—
MKM Partners
Reiterated · Buy · 2022-03-07
—
—
Raymond James
Reiterated · Outperform · 2020-02-26
—
—
SunTrust Robinson Humphrey
Reiterated · Sell · 2020-02-26
—
—
Susquehanna
Downgraded · Positive → Negative · 2020-01-12
—
—
One row per institution · price target from the firm's latest published target